Overview

A Clinical Trial Evaluating the Efficacy and Safety of Sanhuang Jingshiming Pills in the Treatment of nAMD

Status:
NOT_YET_RECRUITING

Trial end date:
2031-12-31

Target enrollment:

Participant gender:

Summary

The purpose of the TSL-TCM-SHJSMW- study is to study the efficacy and safety of Sanhuang Jingshiming Pills in subjects with Neovascular Age-Related Macular Degeneration.

Phase:

PHASE3

Details

Lead Sponsor:

Tasly Pharmaceutical Group Co., Ltd

Treatments:

Ranibizumab